Barolon Tablets (Clonixin Lysinate)

Adult dose

Adults: Administer 125∼250 mg of clonixin lysinate orally 3 times daily.

This medication can increase the risk of gastrointestinal bleeding if taken by individuals who regularly consume more than three alcoholic drinks per day, so it is essential to consult with a doctor or pharmacist. This medication may affect the cardiovascular system, increasing the risk of serious thrombotic reactions such as myocardial infarction or stroke. Special caution is required for individuals with cardiovascular diseases or risk factors, and if any cardiovascular symptoms occur during use, it is important to consult with healthcare professionals immediately. Additionally, this medication may increase the risk of severe gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforations. It is particularly advisable for the elderly or those with a history of gastrointestinal disorders to use it with extra caution, and if symptoms of gastrointestinal bleeding appear, they should stop taking the medication immediately and consult healthcare professionals. This medication should not be taken by patients with peptic ulcers, severe liver disease, or renal impairment, pregnant women, or women who may become pregnant, and those who have allergic reactions to non-steroidal anti-inflammatory drugs. Caution should be exercised to avoid concomitant use with other non-steroidal anti-inflammatory drugs, ACE inhibitors, aspirin, diuretics, lithium, methotrexate, or warfarin, as this may increase the risk of adverse effects due to interactions. Prior to use, it is important to discuss with a doctor, dentist, or pharmacist if there is a history of peptic ulcers, hypertension, heart failure, asthma, liver disease, or renal disease. It is advisable to avoid breastfeeding during treatment with this medication, and if unusual symptoms such as nausea, vomiting, abdominal pain, rash, anemia, hepatic dysfunction, drowsiness, or headache appear, the medication should be stopped immediately, and consultation with healthcare professionals should be sought. This medication should be used at the minimal effective dose and for the shortest duration possible. Regular blood tests and liver and kidney function tests are necessary if used for an extended period. During use, blood pressure and heart condition should be monitored periodically, and if any allergic symptoms such as skin rash or difficulty breathing occur, immediate treatment should be sought. Keep this medication out of reach of children and ensure it is not stored in any other container.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding from the stomach or intestine, ulcer, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, peptic ulcer, shock, rash, itching, anemia, elevation of AST, elevation of ALT, drowsiness, headache, dizziness, cold sweats, chills, abnormal euphoria, jaundice, fulminant hepatitis, hepatic necrosis, hepatic failure, anemia, skin rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, bronchospasm

This medication should be stored in a securely closed, airtight container to prevent air or moisture penetration. This will help maintain the effectiveness of the medication and prevent deterioration.

Appearance

Round, tasteless, and odorless film-coated tablets of white to yellowish color.

Package unit

10 tablets/PTP